Updated on 9 September 2026
马氏细胞中医学三大世界级成果寻求验证合作
董事长 at 中医从业者
China
About
一. 马氏洗骨淸髓疗法,将替代白血病骨髓移植,它可以迅速消 除骨髓炎症和病毒,改变骨髓环境,恢复骨髓造血功能,消除血细胞异常,根除白血病。
经临床验证:一般一月好转,半年至一年康复,寻求验证开发。
二. 马氏中医无形刀,可替代实体瘤手术治疗,启动免疫功能平衡,使癌细胞增殖速度小于免疫杀伤速度,最终达到自然康复。
经临床验证:早起一般80%治愈,中晚期,一般一月使肿瘤影像缩小10mm,CT为证,寻求验证合作。
三.大健康福音——长寿百通饮
打通人体六级循环,激活五脏六腑,将五脏.精.氣.神源源不断输送到全身所有细胞,既延年又益寿,寻求验证合作。
电话:13909248628 2026年8月16日
Project Location
- China
Project Website
http://lkexcellence.com
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- Yes
Project Stage
- Contract Drafting
Main Project Sector
- Agriculture, Food and Rural Development
Public Utilities
- Water & Sanitation
Technology
- Medical Technology
Total Project Value
- 5,000,001 to 7,500,000 USD
Investment Capital Required
- 5,000,001 to 7,500,000 USD
Interested Format of Cooperation
- Direct Equity Investment
- Majority Shareholdings
- Minority Shareholdings
Preferred Financing Model
- Debt
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Bootstrapping
Main Service(s) Required
- Professional Services
Organisation
China
Similar opportunities
Project
- Yes
- Yes
- Debt
- Equity
- Bootstrapping
- Private Project
- Public Utilities
- Water & Sanitation
- Medical Technology
- Open for negotiation
- Open for Negotiation
- Professional Services
- 50,000,001 USD or above
- Feasibility Study Completed
- 10,000,001 to 25,000,000 USD
李士丰 李
董事长 at 中医从业者
China
Project
- Yes
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Health Technology
- Equity (private)
- Medical Technology
- Financial Services
- Open for Negotiation
- 5,000,001 to 7,500,000 USD
- Feasibility Study Completed
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
Roger Zhang
Commercial Director at Centre for Virology, Vaccinology and Therapeutics Limited
China (Hong Kong)
Project
通用型人类多能干细胞来源胰岛类器官糖尿病根治性疗法 (Off-the-shelf Stem Cell-derived Islet Organoid Therapy for Diabetes Cure)
- No
- Yes
- Equity
- Bio-Tech
- Technology
- IP Related
- Legal Advisory
- Equity (private)
- Medical Technology
- Financial Services
- Financial Advisory
- Professional Services
- Minority Shareholdings
- Corporate Intelligence
- Direct Equity Investment
- Institutional Investment
- 2,500,001 to 5,000,000 USD
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
- Public-Private Partnership Project
彬 杨
CEO at 周易生物
China (Hong Kong)